- Dana Foundation Dana Frontiers Grant 2025
- UMN MDTA MIREN Grant 2025
- UMN Department of Psychiatry Grant for Concurrent tACS Trial 2024
- International Network of tES/TMS Trials for Addiction Medicine (INTAM) Grant
- UMN Medical Discovery Team on Addiction Grant for Individualized TMS Trial
Hamed Ekhtiari, M.D.
- Psychiatry
Biography
Hamed Ekhtiari, M.D., Ph.D., graduated from Tehran University of Medical Sciences with his medical degree in 2004 and his Ph.D. in Neuroimaging in 2015. He did his psychiatry residency in University of Minnesota and research fellowship on neuroimaging and neuromodulation at Laureate Institute for Brain Research, Tulsa, OK. He comes to UT Southwestern from the University of Minnesota where he was Associate Director of Clinical Studies on the Medical Discovery Team on Addiction and an Assistant Professor of Psychiatry. Dr. Ekhtiari is a board member and Distinguished Fellow of the International Society for Addiction Medicine (ISAM) and Scientific Director of its Global Innovation Day in Addiction Therapeutics.
Dr. Ekhtiari's research interests include Neural Target Engagement (NTE) Informed Treatment Development and Precision Medicine for People with Substance Use Disorder, using fMRI as an NTE measure, brain stimulation for NTE, and cognitive intervention for augmenting NTE. He has published more than 200 academic papers in his career.
As a division chief, Dr. Ekhtiari will focus on extending innovative and research-based care, faculty development, academic trajectory, and professionalism for the Addiction division.
Honors & Awards
Books & Publications
-
Publications
-
Toward Inclusive, Evidence-Based rTMS Care for Patients With Co-Occurring Substance Use Disorders.
Steele VR, Addicott MA, Addolorato G, Baker T, Biernacki K, Bonci A, Brady KT, Daughters SB, Diana M, Durazzo TC, Ekhtiari H, Fecteau S, Fede SJ, Froeliger B, Gallimberti L, Garza-Villarreal EA, George TP, Goudriaan AE, Heilig M, Kang D, Kearney-Ramos TE, Li X, Lile JA, Madeo G, Madore M, Martinez D, Maretinotti G, McCalley DM, Moeller SJ, Montemitro C, Padula CB, Petersen N, Pettorruso M, Philip NS, Rakesh G, Jo Salmeron B, Sahlem GL, Sanna A, Schütz CG, Schellekens A, Sheffer CE, Soleimani G, Spagnolo PA, Stein EA, Trivedi M, Burrell Ward H, Wesley MJ, Young JR, Yuan K, Yuan T, Zangen A, Zhao D, Zhao M, Hanlon CA, The American journal of psychiatry 2025 Dec 182 12 1095-1096 -
Craving self-reports as outcome measures in drug addiction trials: A systematic review of ClinicalTrials.gov.
Toulami M, Ghasemi K, Rafei P, Sangchooli A, Nafissi N, Khojasteh Zonoozi A, Mohaddes Ardabili H, Ebrahimi M, Rezapour T, Ekhtiari H, Addiction (Abingdon, England) 2025 Oct 120 10 1931-1950 -
Four dimensions of individualization in brain stimulation for psychiatric disorders: context, target, dose, and timing.
Soleimani G, Nitsche MA, Hanlon CA, Lim KO, Opitz A, Ekhtiari H, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2025 May 50 6 857-870 -
Targeting VMPFC-amygdala circuit with TMS in substance use disorder: A mechanistic framework.
Soleimani G, Conelea CA, Kuplicki R, Opitz A, Lim KO, Paulus MP, Ekhtiari H, Addiction biology 2025 Jan 30 1 e70011 -
Clinical translation of expert-endorsed cognitive rehabilitation interventions for substance use disorders.
Verdejo-Garcia A, Berry J, Caracuel A, Copersino ML, Field M, Garland EL, Lorenzetti V, Malloy-Diniz L, Manning V, Marceau EM, Pennington DL, Rezapour T, Strickland JC, Wiers RW, Ekhtiari H, World psychiatry : official journal of the World Psychiatric Association (WPA) 2024 Jun 23 2 299-301 -
Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review.
Sangchooli A, Zare-Bidoky M, Fathi Jouzdani A, Schacht J, Bjork JM, Claus ED, Prisciandaro JJ, Wilson SJ, Wüstenberg T, Potvin S, Ahmadi P, Bach P, Baldacchino A, Beck A, Brady KT, Brewer JA, Childress AR, Courtney KE, Ebrahimi M, Filbey FM, Garavan H, Ghahremani DG, Goldstein RZ, Goudriaan AE, Grodin EN, Hanlon CA, Haugg A, Heilig M, Heinz A, Holczer A, Van Holst RJ, Joseph JE, Juliano AC, Kaufman MJ, Kiefer F, Khojasteh Zonoozi A, Kuplicki RT, Leyton M, London ED, Mackey S, McClernon FJ, Mellick WH, Morley K, Noori HR, Oghabian MA, Oliver JA, Owens M, Paulus MP, Perini I, Rafei P, Ray LA, Sinha R, Smolka MN, Soleimani G, Spanagel R, Steele VR, Tapert SF, Vollstädt-Klein S, Wetherill RR, Witkiewitz K, Yuan K, Zhang X, Verdejo-Garcia A, Potenza MN, Janes AC, Kober H, Zilverstand A, Ekhtiari H, JAMA psychiatry 2024 Apr 81 4 414-425
-
Toward Inclusive, Evidence-Based rTMS Care for Patients With Co-Occurring Substance Use Disorders.